Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
Requisiti di protezione fisica passiva e modalità di redazione dei piani di protezione fisica
Art. 1. Finalità e campo di applicazione
Il presente decreto stabilisce i requisiti ...
ID 16232 | 26.03.2022 / Documento completo allegato
Il Documento illustra con esempi, i requisiti e le caratteristiche tecniche d...
Fire extinguishing and preventive and preparatory measures
Fires at silo sites are rare occurrences for most fire & rescue brigades and are different from conventional fires in many ways.
In...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
